AbbVie Inc (ABBV) Trimmed to Hold at Vetr Inc

Leslie Hanson
April 16, 2018

Green Square Capital LLC now owns 111,177 shares of the company's stock valued at $10,752,000 after purchasing an additional 10,101 shares in the last quarter. The company reported $1.48 earnings per share for the quarter, topping analysts' consensus estimates of $1.44 by $0.04. It also reduced Zillow Group Inc stake by 208,293 shares and now owns 1.79M shares. 4,629,974 shares of the company's stock traded hands, compared to its average volume of 9,016,604. The hedge fund run by Michael Messner held 16,148 shares of the technology company at the end of 2017Q4, valued at $2.85 million, down from 54,600 at the end of the previous reported quarter. It has outperformed by 27.65% the S&P500. BMO Capital Markets reiterated a market perform rating and issued a $63.00 target price on shares of AbbVie in a research note on Tuesday, November 8th. Corporate insiders own 0.07% of the company's stock. About 2.78 million shares traded. 42% are bullish. 24 are the (NYSE:ABBV)'s analyst reports since October 16, 2017 according to StockzIntelligence Inc.

Nelson Roberts Investment Advisors Llc increased its stake in Abbvie Inc. (NYSE:ABBV) for 11,754 shs. Capital International Investors now owns 7,854,929 shares of the company's stock worth $697,989,000 after buying an additional 4,550,954 shares during the period. ABBV's profit will be $2.82 billion for 13.15 P/E if the $1.78 EPS becomes a reality. American Bancshares reported 0.1% in AbbVie Inc.

AbbVie (NYSE:ABBV) last posted its earnings results on Friday, January 27th. The firm has "Buy" rating by Cantor Fitzgerald given on Wednesday, October 28.

Among 23 analysts covering Abbvie Inc (NYSE:ABBV), 10 have Buy rating, 2 Sell and 11 Hold. Therefore 42% are positive. (NYSE:ABBV) on Tuesday, January 30 to "Underperform" rating. On Thursday, November 30 the stock rating was maintained by BMO Capital Markets with "Hold". BMO Capital Markets maintained the stock with "Hold" rating in Sunday, July 30 report. The rating was maintained by Jefferies on Monday, May 29 with "Buy". On Thursday, March 22 SunTrust maintained the shares of ABBV in report with "Buy" rating. (NYSE:ABBV). Marble Harbor Counsel Lc has 198,620 shares for 3.74% of their portfolio. On Monday, March 26 the firm has "Hold" rating by Bank of America given.

Since October 30, 2017, it had 0 buys, and 12 sales for $49.35 million activity.

In related news, VP Robert A. Michael sold 4,294 shares of AbbVie stock in a transaction on Wednesday, February 28th. Also, insider Laura J. Schumacher sold 25,000 shares of AbbVie stock in a transaction on Thursday, March 1st. 8,280 shares were sold by GONZALEZ RICHARD A, worth $976,084 on Wednesday, February 28. The company presently has a consensus rating of Hold and a consensus target price of $69.90. The ex-dividend date is Tuesday, April 11th. This is a positive change from AbbVie's previous quarterly dividend of $0.71. It dropped, as 42 investors sold ABBV shares while 695 reduced holdings. After $1.48 actual EPS reported by AbbVie Inc. for the previous quarter, Wall Street now forecasts 20.27% EPS growth. Chilton Capital Mgmt Ltd Liability Corporation holds 9,820 shs. Carnegie Cap Asset Llc reported 0.5% of its portfolio in RPM International Inc. Us Bancorporation De owns 19,867 shares. Osterweis Cap Mgmt holds 0.03% or 3,670 shares in its portfolio. Investors of record on Friday, April 13th will be given a $0.96 dividend. Loomis Sayles Company Ltd Partnership reported 11,088 shares. Finally, Morse Asset Management Inc boosted its position in AbbVie by 1.7% in the 4th quarter.


According to 2017Q4 Securities and Exchange filling the Visionary Asset Management Inc reduced its holdings in Abbvie Inc (ABBV) by 93.73%. Regions Financial holds 343 shares or 0% of its portfolio. Highland Private Wealth Management now owns 3,259 shares of the company's stock valued at $236,000 after buying an additional 79 shares during the period. (NYSE:ABBV). Atria Invs Lc holds 48,959 shs or 0.24% of its capital. 87,040 shares were sold by RICHMOND TIMOTHY J., worth $8.57M on Monday, December 18. It also increased its holding in Alphabet Class A by 444 shares in the quarter, for a total of 14,851 shares, and has risen its stake in United Technologies Corp (NYSE:UTX). During the same period in the prior year, the company earned $1.20 earnings per share.

Station Casinos Inc (STN) investors sentiment decreased to 1.05 in 2017 Q4. Its down 0.05, from 0.85 in 2017Q3. 139 funds took stakes and 448 increased stakes. Pennsylvania-based Valley Natl Advisers Incorporated has invested 0.18% in JPMorgan Chase & Co. The company offers HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases; IMBRUVICA, an oral therapy for the treatment of patients with chronic lymphocytic leukemia; and VIEKIRA PAK, an interferon-free therapy, with or without ribavirin, for the treatment of adults with genotype 1 chronic hepatitis C. (NYSE:HCA) for 71,370 shares.

Shares of AbbVie stock opened at $91.83 on Friday. Finally, WASHINGTON TRUST Co raised its stake in shares of AbbVie by 1.1% in the third quarter. (NYSE:ABBV) to report earnings on April, 26. $8.31M worth of AbbVie Inc. 50,000 were accumulated by Iguana Health Management Limited Liability. Capital Research Global Investors who had been investing in Abbvie Inc for a number of months, seems to be bullish on the $145.71 billion market cap company.

Sterling Capital Management Llc, which manages about $45.64B and $11.05B US Long portfolio, upped its stake in Merck & Co Inc New Com (NYSE:MRK) by 135,439 shares to 1.58M shares, valued at $88.69M in 2017Q4, according to the filing.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Other reports by Iphone Fresh

Discuss This Article

FOLLOW OUR NEWSPAPER